Latest Articles

Analysts Have a 3 Recommendation on Grana y Montero S.A.A. (NYSE:GRAM)

Analysts Have a 3 Recommendation on Grana y Montero S.A.A. (NYSE:GRAM)

Grana y Montero S.A.A. (NYSE:GRAM) shares have traded 2.02% for the week and are 23.86% so far this year. At the time of writing, the stock is checking in at $3.53, a change of -0.56% from the previous close. In terms of volatility, the average daily high/low percentage range sits at 6.00% for […]

Are Analysts Making a Convincing Case for Cowen Inc. (NASDAQ:COWN)?

Are Analysts Making a Convincing Case for Cowen Inc. (NASDAQ:COWN)?

Covering Wall Street firms have recently weighed in on Cowen Inc. (NASDAQ:COWN) shares. At the time of writing, the mean target price for the firm is $16. The current combined recommendation provided by covering Wall Street analysts is 2. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of […]

RSI Touches 51.33 For Companhia Energetica de Minas Gerais (NYSE:CIG)

RSI Touches 51.33 For Companhia Energetica de Minas Gerais (NYSE:CIG)

Companhia Energetica de Minas Gerais (NYSE:CIG) currently has an average analyst recommendation of 2 according to analysts on Wall Street. This is the average number based on the total brokerage firms taken into consideration by BSR. The same analysts have a future one-year price target of $3.1 on the shares. […]

What’s Next For Alimera Sciences, Inc. (NASDAQ:ALIM) As Shares Move 1.82% For Week

What’s Next For Alimera Sciences, Inc. (NASDAQ:ALIM) As Shares Move 1.82% For Week

Covering sell-side analysts have recently weighed in on shares of Alimera Sciences, Inc. (NASDAQ:ALIM). At the time of writing, the consensus price target for the company is $3.5. The current consensus recommendation provided by covering analysts is 2. This recommendation lands on a scale between 1 and 5. Analysts giving […]

Showing Signs of Life?  Stock Update on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

Showing Signs of Life? Stock Update on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)

The stats on AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) are currently as follows. The weekly performance is -8.29%, and the quarterly performance is at 39.71%. The monthly performance is -1.53% and the yearly performance is -1.53%. The performance for Year to Date (YTD) is 46.04%. Taking a deeper look into the volatility on […]

Hashing Out the Numbers: Checking on the Technicals for Aileron Therapeutics Inc (:ALRN)

Hashing Out the Numbers: Checking on the Technicals for Aileron Therapeutics Inc (:ALRN)

According to the most recent SEC filings, corporate insiders at Aileron Therapeutics, Inc. (:ALRN) have moved their positions in the stock by 0.00% over the past 6 months. Insiders now own 11.20% of total outstanding shares. The SEC says that an “insider” is anyone who owns at least a 10% stake […]

Is Companhia Paranaense de Energia – COPEL (NYSE:ELP) Invest-able with a Beta of 1.31?

Is Companhia Paranaense de Energia – COPEL (NYSE:ELP) Invest-able with a Beta of 1.31?

Traders may be interested in various technical levels on shares of Companhia Paranaense de Energia – COPEL (NYSE:ELP). After a recent check, the Williams %R was spotted at -76.25. Levels can range from 0 to -100.  A number charting between -80 to -100 may be typically viewed as strong oversold territory. […]

What’s Next For Valeant Pharmaceuticals International, Inc. (NYSE:VRX) As Shares Move 0.17% For Week

What’s Next For Valeant Pharmaceuticals International, Inc. (NYSE:VRX) As Shares Move 0.17% For Week

Since the beginning of the calendar year, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) is -17.32%. For the quarter, shares have been noted at -20.17%. Share performance for the month is currently at 4.63%. Tightening the gaze, stock performance for the last 5 trading days is 0.17%. Covering sell-side analysts have recently […]

Is Akebia Therapeutics, Inc. (NASDAQ:AKBA) Invest-able with a Beta of 1.07?

Is Akebia Therapeutics, Inc. (NASDAQ:AKBA) Invest-able with a Beta of 1.07?

Akebia Therapeutics, Inc. (NASDAQ:AKBA) has a 14-day Commodity Channel Index (CCI) of -151.53. The CCI was designed to typically remain within the reading of -100 to +100. Traders may use the indicator to spot stock trends or to seek out overbought/oversold conditions. A CCI reading over +100 would suggest that […]

Is Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR)’s Target Price of $26.17 Reasonable?

Is Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR)’s Target Price of $26.17 Reasonable?

Alder Biopharmaceuticals, Inc. (NASDAQ:ALDR) currently has a 14-day Commodity Channel Index (CCI) of 24.91. Dedicated investors may choose to use this technical indicator as a stock evaluation tool. Used as a coincident indicator, the CCI reading above +100 would reflect strong price action which may signal an uptrend. On the […]